CDC & FDA recommend a pause on Johnson & Johnson COVID-19 vaccine
Breaking News
Federal health agencies are calling for an immediate pause in the use of Johnson & Johnson’s single-dose coronavirus vaccine after six recipients in the United States developed a rare disorder involving blood clots within two weeks of vaccinations.
All six recipients were women between the ages of 18 and 48. One woman died and second woman has been hospitalized in critical condition.
Around seven million people in the United States have received Johnson & Johnson shots so far. Nine million shots have been shipped out to the states according to the data from the Centers for Disease Control and Prevention.
